Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Total Non-Current Liabilities (2016 - 2026)

Integra Lifesciences Holdings' Total Non-Current Liabilities history spans 17 years, with the latest figure at $2.4 billion for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities changed 0.36% to $2.4 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.4 billion, a 0.36% change, with the full-year FY2025 number at $2.4 billion, changed 0.36% from a year prior.
  • Total Non-Current Liabilities hit $2.4 billion in Q4 2025 for Integra Lifesciences Holdings, down from $2.4 billion in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for IART hit a ceiling of $2.4 billion in Q2 2024 and a floor of $1.9 billion in Q1 2023.
  • Historically, Total Non-Current Liabilities has averaged $2.1 billion across 5 years, with a median of $2.0 billion in 2022.
  • Biggest five-year swings in Total Non-Current Liabilities: decreased 4.66% in 2022 and later grew 22.89% in 2024.
  • Tracing IART's Total Non-Current Liabilities over 5 years: stood at $2.0 billion in 2021, then increased by 3.81% to $2.1 billion in 2022, then dropped by 2.85% to $2.0 billion in 2023, then rose by 17.64% to $2.3 billion in 2024, then grew by 0.36% to $2.4 billion in 2025.
  • Business Quant data shows Total Non-Current Liabilities for IART at $2.4 billion in Q4 2025, $2.4 billion in Q3 2025, and $2.4 billion in Q2 2025.